SCHEMBL197122

SCHEMBL197122

CN(C)[C@@H](CS)C(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8721546 1.00 — —
SCHEMBL197121 1.00 — —
Hydrochloric Acid SCHEMBL9807456 0.97 PTGS1 (0.39) —
Hydrochloric Acid SCHEMBL8945311 0.97 PTGS1 (0.39) —
Hydrochloric Acid SCHEMBL9807458 0.97 PTGS1 (0.39) —
Hydrochloric Acid SCHEMBL8945317 0.97 PTGS1 (0.39) —
Carbamic Acid SCHEMBL30002433 0.93 PTGS1 (0.41) —
SCHEMBL9298599 0.82 — —
SCHEMBL4263223 0.82 — —
SCHEMBL4263221 0.82 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 478 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-120118311-A Continuous method for preparing TMQ polymer, product and application 上海华谊新材料有限公司 2025-06-10 — — CN claimed
US-20230331767-A1 TARGETED STEROID COMPOUNDS PURDUE RESEARCH FOUNDATION 2023-10-19 — — US claimed
EP-4087580-A1 TARGETED STEROID COMPOUNDS Purdue Research Foundation (US) 2022-11-16 — — EP claimed
CN-115003308-A Targeted steroid compounds 普渡研究基金会 2022-09-02 — — CN claimed
US-20160244484-A1 ANTI-INFLAMMATORY TRIPEPTIDES DR. AUGUST WOLFF GMBH & CO. KG ARZNEIMITTEL (DE) 2016-08-25 — — US claimed
EP-3049428-A1 ANTI-INFLAMMATORY TRIPEPTIDES Dr. August Wolff GmbH & Co. KG Arzneimittel (DE) 2016-08-03 — — EP claimed
WO-2015040235-A1 ANTI-INFLAMMATORY TRIPEPTIDES DR. AUGUST WOLFF GMBH & CO. KG ARZNEIMITTEL (DE) 2015-03-26 — — WO claimed
EP-0948258-A4 BRAIN TARGETED LOW MOLECULAR WEIGHT HYDROPHOBIC ANTIOXIDANT COMPOUNDS YISSUM RES DEV CO (IL) 2004-12-01 — — EP claimed
EP-0948258-A1 BRAIN TARGETED LOW MOLECULAR WEIGHT HYDROPHOBIC ANTIOXIDANT COMPOUNDS YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM (IL) 1999-10-13 — — EP claimed
WO-1998029375-A1 BRAIN TARGETED LOW MOLECULAR WEIGHT HYDROPHOBIC ANTIOXIDANT COMPOUNDS YISSUM RESEARCH AND DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM (IL) 1998-07-09 — — WO claimed
EP-3381434-B1 DENTAL PRIMER AND KIT FOR DENTAL PROSTHESIS ADHESION G C DENTAL IND CORP (JP) 2026-04-29 — — EP disclosed
EP-4688001-A1 AN INJECTABLE DELIVERY SYSTEM FOR LONG-ACTING ADMINISTRATION OF DRUGS Queen's University of Belfast (GB) 2026-02-11 — — EP disclosed
US-12497476-B2 Antibacterial polymer particles, composition, and article GC CORPORATION (JP) 2025-12-16 — — US disclosed
WO-2025215218-A1 PEPTIDES AND PEPTIDOMIMETICS TO DESTABILIZE THE SYNAPTIC COMPLEX OF A RECOMBINASE Technische Universität Dresden, Körperschaft des öffentlichen Rechts (DE) 2025-10-16 — — WO disclosed
US-20250222117-A1 COMPOUND COMPRISING RALTITREXED OR 5-MTHF LINKED TO A THERAPEUTIC AGENT, COMPOSITION, AND METHOD OF USE PURDUE RESEARCH FOUNDATION 2025-07-10 — — US disclosed
EP-0341915-A2 Anti-aggregatory peptides SMITHKLINE BEECHAM CORPORATION (US) 1989-11-15 — — EP disclosed
EP-0226591-A1 ANTI-TUMOR COMPOSITIONS CONTAINING THE REACTION PRODUCT OF A CYTOTOXIC ALDEHYDE WITH PENICILLAMINE AND THEIR USE FOR THE MANUFACTURE OF MEDICAMENTS. RUBIN DAVID 1987-07-01 — — EP disclosed
EP-0226591-A4 ANTI-TUMOR COMPOSITIONS CONTAINING THE REACTION PRODUCT OF A CYTOTOXIC ALDEHYDE WITH PENICILLAMINE AND THEIR USE FOR THE MANUFACTURE OF MEDICAMENTS. RUBIN DAVID 1987-06-01 — — EP disclosed
WO-1986003677-A1 ANTI-TUMOR COMPOSITIONS CONTAINING THE REACTION PRODUCT OF A CYTOTOXIC ALDEHYDE WITH PENICILLAMINE AND METHOD OF USE THEREOF RUBIN DAVID 1986-07-03 — — WO disclosed
US-4344956-A Oxotetrahydrothiophenes ERCOLI NICOLO 1982-08-17 — — US disclosed
Send feedback